{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:11:26Z","timestamp":1792591886538,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003252","name":"Lunds Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jtha.2024.08.003","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T01:55:13Z","timestamp":1724378113000},"page":"3266-3276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["CpG oligonucleotides induce acute murine thrombocytopenia dependent on toll-like receptor 9 and spleen tyrosine kinase pathways"],"prefix":"10.1016","volume":"22","author":[{"given":"Karl","family":"Johansson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Maouia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Rebetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Marcoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oonagh","family":"Shannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Joseph E.","family":"Italiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padma","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijiang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Semple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.08.003_bib1","doi-asserted-by":"crossref","first-page":"15553","DOI":"10.1073\/pnas.95.26.15553","article-title":"CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice","volume":"95","author":"Brazolot Millan","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2024.08.003_bib2","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1093\/nar\/gkaa299","article-title":"Phosphorothioate modified oligonucleotide-protein interactions","volume":"48","author":"Crooke","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jtha.2024.08.003_bib3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.coi.2008.07.007","article-title":"Accessing the therapeutic potential of immunostimulatory nucleic acids","volume":"20","author":"Barchet","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jtha.2024.08.003_bib4","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1128\/IAI.67.11.5658-5663.1999","article-title":"Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection","volume":"67","author":"Klinman","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.jtha.2024.08.003_bib5","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1172\/JCI31414","article-title":"Development of TLR9 agonists for cancer therapy","volume":"117","author":"Krieg","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2024.08.003_bib6","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.neuron.2017.04.010","article-title":"Antisense oligonucleotides: translation from mouse models to human neurodegenerative diseases","volume":"94","author":"Schoch","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.jtha.2024.08.003_bib7","first-page":"347","article-title":"Antisense oligonucleotides: basic concepts and mechanisms","volume":"1","author":"Dias","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jtha.2024.08.003_bib8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1089\/ard.1993.3.383","article-title":"Systemic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trial","volume":"3","author":"Bayever","year":"1993","journal-title":"Antisense Res Dev"},{"key":"10.1016\/j.jtha.2024.08.003_bib9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jtha.2024.08.003_bib10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41582-019-0210-4","article-title":"Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease","volume":"15","author":"Adams","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jtha.2024.08.003_bib11","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1146\/annurev-pharmtox-010818-021050","article-title":"Therapeutic oligonucleotides: state of the art","volume":"59","author":"Smith","year":"2019","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.jtha.2024.08.003_bib12","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3390\/vaccines3020390","article-title":"CpG oligonucleotides as cancer vaccine adjuvants","volume":"3","author":"Shirota","year":"2015","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jtha.2024.08.003_bib13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","article-title":"CpG motifs in bacterial DNA and their immune effects","volume":"20","author":"Krieg","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jtha.2024.08.003_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1084\/jem.20140391","article-title":"Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators","volume":"212","author":"Flierl","year":"2015","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jtha.2024.08.003_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187574","article-title":"Assessing single-stranded oligonucleotide drug-induced effects in\u00a0vitro reveals key risk factors for thrombocytopenia","volume":"12","author":"Sewing","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.jtha.2024.08.003_bib16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.thromres.2021.01.006","article-title":"Antisense oligonucleotides and nucleic acids generate hypersensitive platelets","volume":"200","author":"Zaslavsky","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.08.003_bib17","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/toxsci\/kfy119","article-title":"Investigation into the mechanism(s) that leads to platelet decreases in cynomolgus monkeys during administration of ISIS 104838, a 2\u2032-MOE-modified antisense oligonucleotide","volume":"164","author":"Narayanan","year":"2018","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jtha.2024.08.003_bib18","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1093\/nar\/gkaa126","article-title":"Comparison of the efficacy of MOE and PMO modifications of systemic antisense oligonucleotides in a severe SMA mouse model","volume":"48","author":"Sheng","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jtha.2024.08.003_bib19","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/nbt759","article-title":"Systemically delivered antisense oligomers upregulate gene expression in mouse tissues","volume":"20","author":"Sazani","year":"2002","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jtha.2024.08.003_bib20","doi-asserted-by":"crossref","first-page":"7595","DOI":"10.1073\/pnas.88.17.7595","article-title":"Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice","volume":"88","author":"Agrawal","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2024.08.003_bib21","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.186.7.1027","article-title":"A\u00a0critical role for Syk in signal transduction and phagocytosis mediated by Fcgamma receptors on macrophages","volume":"186","author":"Crowley","year":"1997","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jtha.2024.08.003_bib22","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1084\/jem.186.10.1623","article-title":"CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity","volume":"186","author":"Chu","year":"1997","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jtha.2024.08.003_bib23","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1182\/blood.V89.8.2994","article-title":"Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma","volume":"89","author":"Wooldridge","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.08.003_bib24","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.4049\/jimmunol.160.6.2555","article-title":"Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma","volume":"160","author":"Kline","year":"1998","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jtha.2024.08.003_bib25","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1089\/oli.1.1997.7.575","article-title":"Toxicologic effects of an oligodeoxynucleotide phosphorothioate and its analogs following intravenous administration in rats","volume":"7","author":"Agrawal","year":"1997","journal-title":"Antisense Nucleic Acid Drug Dev"},{"key":"10.1016\/j.jtha.2024.08.003_bib26","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1172\/JCI38294","article-title":"CpG-containing immunostimulatory DNA sequences elicit TNF-alpha-dependent toxicity in rodents but not in humans","volume":"119","author":"Campbell","year":"2009","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2024.08.003_bib27","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.3892\/ijo.2014.2356","article-title":"The secretion of IL-6 by CpG-ODN-treated cancer cells promotes T-cell immune responses partly through the TLR-9\/AP-1 pathway in oral squamous cell carcinoma","volume":"44","author":"Ruan","year":"2014","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jtha.2024.08.003_bib28","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/icb.2011.9","article-title":"IFN-\u03b3-mediated efficacy of allergen-free immunotherapy using mycobacterial antigens and CpG-ODN","volume":"89","author":"Fonseca","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jtha.2024.08.003_bib29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J\u00a0Interferon Cytokine Res"},{"key":"10.1016\/j.jtha.2024.08.003_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103820","article-title":"Recent advances in the mechanisms and treatment of immune thrombocytopenia","volume":"76","author":"Provan","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jtha.2024.08.003_bib31","first-page":"16","article-title":"Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP)","volume":"6","author":"Zufferey","year":"2017","journal-title":"J\u00a0Clin Med"},{"issue":"Suppl 1","key":"10.1016\/j.jtha.2024.08.003_bib32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2249.2009.04022.x","article-title":"Intravenous immunoglobulins--understanding properties and mechanisms","volume":"158","author":"Durandy","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jtha.2024.08.003_bib33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3389\/fimmu.2015.00197","article-title":"Differences in anti-inflammatory actions of intravenous immunoglobulin between mice and men: more than meets the eye","volume":"6","author":"Tjon","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2024.08.003_bib34","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/intimm\/dxx039","article-title":"IVIG-mediated effector functions in autoimmune and inflammatory diseases","volume":"29","author":"Galeotti","year":"2017","journal-title":"Int Immunol"},{"key":"10.1016\/j.jtha.2024.08.003_bib35","article-title":"Effect of intravenous immunoglobulin on the function of Treg cells derived from immunosuppressed mice with Pseudomonas aeruginosa pneumonia","volume":"12","author":"Li","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.jtha.2024.08.003_bib36","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jaci.2020.06.036","article-title":"Dissecting the mechanism of action of intravenous immunoglobulin in human autoimmune disease: lessons from therapeutic modalities targeting Fc\u03b3 receptors","volume":"146","author":"Shock","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jtha.2024.08.003_bib37","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3324\/haematol.2020.260059","article-title":"Sequence-specific 2\u2032-O-methoxyethyl antisense oligonucleotides activate human platelets through glycoprotein VI, triggering formation of platelet-leukocyte aggregates","volume":"107","author":"Slingsby","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2024.08.003_bib38","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3390\/pharmaceutics15041112","article-title":"Platelet activation by antisense oligonucleotides (ASOs) in the G\u00f6ttingen minipig, including an evaluation of\u00a0glycoprotein VI (GPVI) and platelet factor 4 (PF4) ontogeny","volume":"15","author":"Valenzuela","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jtha.2024.08.003_bib39","doi-asserted-by":"crossref","first-page":"28029","DOI":"10.1074\/jbc.270.47.28029","article-title":"Cyclic AMP-insensitive activation of c-Src and Syk protein-tyrosine kinases through platelet membrane glycoprotein VI","volume":"270","author":"Ichinohe","year":"1995","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.08.003_bib40","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.3390\/ijms20112788","article-title":"Role of platelet glycoprotein VI and tyrosine kinase Syk in thrombus formation on collagen-like surfaces","volume":"20","author":"Jooss","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2024.08.003_bib41","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1111\/j.1538-7836.2011.04470.x","article-title":"The Syk-kinase inhibitor R406 impairs platelet activation and monocyte tissue factor expression triggered by heparin-PF4 complex directed antibodies","volume":"9","author":"Lhermusier","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.08.003_bib42","doi-asserted-by":"crossref","first-page":"C902","DOI":"10.1152\/ajpcell.00296.2020","article-title":"Assessment of the effects of Syk and BTK inhibitors on GPVI-mediated platelet signaling and function","volume":"320","author":"Zheng","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jtha.2024.08.003_bib43","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.4049\/jimmunol.171.3.1393","article-title":"Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation","volume":"171","author":"Gursel","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jtha.2024.08.003_bib44","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/1521-4141(200205)32:5<1212::AID-IMMU1212>3.0.CO;2-D","article-title":"Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells","volume":"32","author":"Stunz","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jtha.2024.08.003_bib45","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1182\/blood-2005-06-2202","article-title":"Platelet toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in\u00a0vivo","volume":"107","author":"Aslam","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.08.003_bib46","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1083\/jcb.201111136","article-title":"T\u00a0granules in human platelets function in TLR9 organization and signaling","volume":"198","author":"Thon","year":"2012","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.jtha.2024.08.003_bib47","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.thromres.2004.03.023","article-title":"Expression of toll-like receptors on human platelets","volume":"113","author":"Shiraki","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.08.003_bib48","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1440-1711.2005.01314.x","article-title":"Evidence of toll-like receptor molecules on human platelets","volume":"83","author":"Cognasse","year":"2005","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jtha.2024.08.003_bib49","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1182\/blood-2005-03-0916","article-title":"Platelets express functional toll-like receptor-4","volume":"106","author":"Andonegui","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.08.003_bib50","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1182\/blood-2005-08-3219","article-title":"Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome","volume":"108","author":"St\u00e5hl","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.08.003_bib51","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1152\/japplphysiol.01576.2005","article-title":"In\u00a0vivo effects of lipopolysaccharide and TLR4 on platelet production and activity: implications for thrombotic risk","volume":"102","author":"Jayachandran","year":"2007","journal-title":"J\u00a0Appl Physiol (1985)"},{"key":"10.1016\/j.jtha.2024.08.003_bib52","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nm1565","article-title":"Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood","volume":"13","author":"Clark","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jtha.2024.08.003_bib53","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1182\/blood-2006-12-062695","article-title":"Platelet-bound lipopolysaccharide enhances Fc receptor-mediated phagocytosis of IgG-opsonized platelets","volume":"109","author":"Semple","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.08.003_bib54","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/CIRCRESAHA.108.185785","article-title":"Stimulation of toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase","volume":"104","author":"Blair","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.jtha.2024.08.003_bib55","doi-asserted-by":"crossref","first-page":"6150","DOI":"10.3390\/ijms21176150","article-title":"Revisiting platelets and toll-like receptors (TLRS): at the interface of vascular immunity and thrombosis","volume":"21","author":"Hally","year":"2020","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624004793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624004793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T21:37:47Z","timestamp":1734557867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624004793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":55,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1538783624004793"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.08.003","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CpG oligonucleotides induce acute murine thrombocytopenia dependent on toll-like receptor 9 and spleen tyrosine kinase pathways","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}